You have 9 free searches left this month | for more free features.

K562

Showing 1 - 25 of 657

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma Trial in Boston (Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells)

Active, not recruiting
  • Follicular Lymphoma
  • Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 28, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • GM-K562/leukemia cell vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 15, 2020

Chronic Lymphocytic Leukemia Trial in Boston (GM-K562 vaccine, stem cell transplantation)

Completed
  • Chronic Lymphocytic Leukemia
  • GM-K562 vaccine
  • stem cell transplantation
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 15, 2020

Leukemia Trial in Boston (GM-K562 cell vaccine, imatinib mesylate)

Completed
  • Leukemia
  • GM-K562 cell vaccine
  • imatinib mesylate
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 26, 2020

Sarcoma, Melanoma, Epithelial Malignancies Trial run by the NCI (Cyclophosphamide, Allogenic tumor Cell Vaccine (K562),

Terminated
  • Sarcoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020

Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma Trial run by the NCI (Allogeneic Tumor Cell Vaccine (K562),

Terminated
  • Lung Cancer
  • +4 more
  • Allogeneic Tumor Cell Vaccine (K562)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020

Healthy Volunteers Trial in Jackson (Immulina TM, Placebo)

Recruiting
  • Healthy Volunteers
  • Immulina TM
  • Placebo
  • Jackson, Mississippi
    University of Mississippi Medical Center
Aug 23, 2022

MDS Trial in Baltimore (K562/GM-CSF cell vaccine)

Terminated
  • Myelodysplastic Syndromes
  • K562/GM-CSF cell vaccine
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 18, 2018

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Upper Respiratory Infection Trial in Seoul (Allium Cepa L. Peel Heated Water Extract, Placebo)

Active, not recruiting
  • Upper Respiratory Infection
  • Allium Cepa L. Peel Heated Water Extract
  • Placebo
  • Seoul, Korea, Republic of
    Hanyang University
Dec 27, 2022

Renal Dialysis, Hyperphosphatemia, Dietary Modification Trial in Ireland (Current Low Phosphorus Diet Prescription, Modified Low

Completed
  • Renal Dialysis
  • +2 more
  • Current Low Phosphorus Diet Prescription
  • Modified Low Phosphorus Diet Prescription
  • Tullamore, Offaly, Ireland
  • +9 more
Jan 15, 2020

Leukemia Trial in Baltimore (GM-K562 cell vaccine, Interferon alfa, Sargramostim)

Completed
  • Leukemia
  • GM-K562 cell vaccine
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 10, 2018

Acute Myeloid Leukemia Trial in Minsk (Expanded haploidentical NK cells)

Recruiting
  • Acute Myeloid Leukemia
  • Expanded haploidentical NK cells
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Apr 12, 2022

Mild Cognitive Impairment Trial in Ottawa (Memory Support System)

Not yet recruiting
  • Mild Cognitive Impairment
  • Memory Support System
  • Ottawa, Ontario, Canada
    Bruyere Research Institute
Aug 10, 2023

Diabetic Macular Edema Trial (K8)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Jan 27, 2023

Ulcerative Colitis Trial in Worldwide (PTG-100, Placebo)

Terminated
  • Ulcerative Colitis
  • Los Angeles, California
  • +97 more
Sep 24, 2021

Acute Myeloid Leukemia Trial in Minsk (NK cell infusions)

Recruiting
  • Acute Myeloid Leukemia
  • NK cell infusions
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Feb 28, 2022

Hyperlipidemia Trial in Worldwide (Evolocumab, Placebo to Evolocumab)

Completed
  • Hyperlipidemia
  • Evolocumab
  • Placebo to Evolocumab
  • Birmingham, Alabama
  • +99 more
Jan 4, 2021

Leukemia, Acute Myeloid, Leukemia, Acute Lymphoblastic Trial in Minsk (Expanded Haploidentical Natural Killer cells, IL-2)

Completed
  • Leukemia, Acute Myeloid
  • Leukemia, Acute Lymphoblastic
  • Expanded Haploidentical Natural Killer cells
  • IL-2
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Feb 28, 2022

Healthy Volunteers, Spinal Cord Injury, Stroke Trial in Manhasset (Transcutaneous Electrical Stimulation)

Recruiting
  • Healthy Volunteers
  • +5 more
  • Transcutaneous Electrical Stimulation
  • Manhasset, New York
    Northwell Health's The Feinstein Institute for Medical Research
Dec 28, 2022

Binge Eating Trial in San Antonio (Binge Eating Syndrome Treatment (BESTOW))

Recruiting
  • Binge Eating
  • Binge Eating Syndrome Treatment (BESTOW)
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Apr 6, 2023

Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive

Active, not recruiting
  • Human Papillomavirus-Related Carcinoma
  • +5 more
  • HPV Specific T Cells
  • +3 more
  • Houston, Texas
    Houston Methodist Hospital
Jan 10, 2022

sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

Completed
  • Chronic Myeloid Leukemia
  • ELISA kit
  • Tanta, Egypt
    Tanta University
May 18, 2022

Multiple Sclerosis Trial in Ottawa (Lifestyle Physical Activity, General Wellness)

Recruiting
  • Multiple Sclerosis
  • Lifestyle Physical Activity
  • General Wellness
  • Ottawa, Ontario, Canada
    University of Ottawa
Nov 23, 2022

Mild Cognitive Impairment Trial in Ottawa (Memory Support System)

Recruiting
  • Mild Cognitive Impairment
  • Memory Support System
  • Ottawa, Ontario, Canada
    Bruyere Research Institute
Apr 29, 2022